Product Information
NORPACE CR 100 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $4.1412 per EA under NDC 00025273231. Its NADAC has been published 138 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the disopyramide phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Pfizer Inc.NDC
00025273231
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2025
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA018655On Market Since
7/20/1982
Pharmacological Classes
Price Statistics
The NADAC for NORPACE CR 100 MG CAPSULE has been published 138 times since Nov 28, 2013, and over the history we have for it it has risen 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1412 per EA |
|---|---|
| All-time high | $4.1412 (Jan 14, 2026) |
| All-time low | $2.2254 (Nov 28, 2013) |
| 52-week high | $4.1412 |
| 52-week low | $4.1412 |
| Median price | $2.3811 |
| Average price | $3.0746 |
| Largest weekly change | +76.9% (Dec 18, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORPACE CR 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NORPACE CR 100 MG CAPSULE, manufactured by Pfizer Inc., is $4.1412 per EA (NDC 00025273231), effective Jan 14, 2026.
How has the price of NORPACE CR 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NORPACE CR 100 MG CAPSULE has risen 86.1%. It has been tracked across 138 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORPACE CR 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for NORPACE CR 100 MG CAPSULE has ranged from a low of $2.2254 (Nov 28, 2013) to a high of $4.1412 (Jan 14, 2026), with a median of $2.3811 per EA.
Are there cheaper alternatives to NORPACE CR 100 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DISOPYRAMIDE 100 MG CAPSULE, is $0.8437 per EA — about 80% below NORPACE CR 100 MG CAPSULE.
Who manufactures NORPACE CR 100 MG CAPSULE?
NORPACE CR 100 MG CAPSULE (NDC 00025273231) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification